UNSPSC 85722368: Supplement right toe phalangeal joint with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right toe phalangeal joint with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SUP4KZ

UNSPSC 85722368 Supplement right toe phalangeal joint with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent state and local procurement activity. The code describes a specific orthopedic surgical procedure (joint replacement of the right big toe using non-human tissue via minimally invasive technique), yet the recent opportunities tagged under it consist of general medical services—disability evaluation coordination, surgical benefit carve-out administration, occupational health surveillance, juvenile detention medical services, pharmacy benefit management, and temporary health professional staffing—none of which involve orthopedic implants or toe joint procedures. State and local procurement offices do not systematically solicit orthopedic implants or surgical supplies through formal RFP and RFQ processes at the commodity-code level; instead, hospitals and health systems typically procure such items through group purchasing organizations, established vendor agreements, or standing orders managed at the facility or system level.

The mismatch between the code's clinical specificity and the actual procurement activity suggests either a cataloging error in how opportunities were tagged or a fundamental misalignment between this taxonomy category and the way state and local healthcare entities conduct medical device and supply procurement. No recent opportunities in the source show active solicitation for orthopedic joint supplements, surgical implants, or related materials. Business development activity under this code should focus on identifying whether state and local health systems use cooperative purchasing vehicles (such as GPO contracts or state health department group buys) for orthopedic implants, rather than pursuing RFP-level procurement notices, which do not appear in the current market signal.